We have previously reported the modulation of 5-LOX with iron cellular content [61], so we analyzed the expression levels of this enzyme and its leukotriene B4 (LTB4) products in relation to COVID-19 and long-COVID patients. This evidence concerns the gene ALOX5 and COVID-19.